Islet transplantation into the portal vein is the current clinical practice. However, it has now been recognized that this implantation site has several characteristics that can hamper islet engraftment and survival, such as low oxygen tension, an active innate immune system, and the provocation of an inflammatory response (IBMIR). These factors result in the loss of many transplanted islets, mainly during the first hours or days after transplantation, which could in part explain the necessity for the transplantation of islets from multiple pancreas donors to cure type 1 diabetes. This increases the burden on the limited pool of donor organs. Therefore, an alternative anatomical site for islet transplantation that offers maximum engraftment, efficacious use of produced insulin, and maximum patient safety is urgently needed. In this review, the experience with alternative sites for islet implantation in clinical and experimental models is discussed. Subcutaneous transplantation guarantees maximum patient safety and has become clinically applicable. Future improvements could be achieved with innovative designs for devices to induce neovascularization and protect the islets from cellular rejection. However, other sites, such as the omentum, offer drainage of produced insulin into the portal vein for direct utilization in the liver. The use of pigs would not only overcome the shortage of transplantable islets, but genetic modification could result in the expression of human genes, such as complement regulatory or "anticoagulation" genes in the islets to overcome some site-specific disadvantages. Eventually, the liver will most likely be replaced by a site that allows long-term survival of islets from a single donor to reverse type 1 diabetes.
INTRODUCTION
replicate in some other centers (72, 75) . In addition to auto-and alloimmune barriers, the survival of an islet transplant depends on the diffusion of oxygen and nutriThe islets of Langerhans are scattered throughout the exocrine tissue of the pancreas, providing the organ with ents provided by the particular site of Tx, and on the revascularization of the graft at that site. Ideally, the opits specific anatomical architecture. The development of a reproducible automatic method for islet isolation (67) timal site would allow for maximum islet survival, maximal efficacious use of the produced insulin, and maxicreated the possibility for islet transplantation (Tx) to reconstruct natural glucose homeostasis in type 1 diamum patient safety. It has now been recognized that the liver may not provide the conditions that can meet these betic patients, while avoiding Tx of the exocrine tissue. Today, clinical islet Tx into the portal vein can be sucrequirements. The future of islet Tx will in part depend on identifying a Tx site that can allow for long-term cessful in experienced centers (23, 33, 75) .
However, after the initial promising results of the Edengraftment of islets from a single donor to reverse type 1 diabetes. monton protocol (74) , long-term graft function has been rather disappointing, and the successes proved hard to Since the first islet Tx experiments, many other sites 1006 VAN DER WINDT ET AL.
than the liver have been explored, with various success subsequent experiments, normoglycemia could be restored if the islets were transplanted into the portal vein rates. In humans, islets have been transplanted under the kidney capsule, into the spleen, into the peritoneal cavof syngeneic rat recipients (44) . The results of intraportal Tx were significantly superior to intraperitoneal and ity, into the muscles of the abdomen and forearm, and under the skin (20, 51, 65, 73, 85) . In rodent and in large subcutaneous Tx (43) . Also, in human patients, the firstalbeit modest-successes of islet autoTx after pananimal models, various sites have been explored in order to overcome problems that can hamper islet engraftcreatectomy for chronic pancreatitis were obtained after intraportal infusion (58). ment; these include mechanical stress, immune activity, inflammatory responses, oxygen and nutrient supply, and When the automatic method for islet isolation was introduced in 1986 (67), the collection of human islets clinical feasibility. Although many experiments were carried out, as we now know, under suboptimal technical in consistent yields sufficient for clinical transplantion became a reality. This led to the first clinical successes conditions or suboptimal or harmful immune suppression, it is still worthy to review these experiences in our of intraportal islet alloTx (83) . Subsequent improvements in outcome depended mainly on the introduction search for the optimal site for islet Tx.
This review will briefly discuss the advantages and of a steroid-free immunosuppressive protocol and the Tx of islets from more than one donor (74) . disadvantages of the liver and other sites for islet Tx in human and animal research, with relevance for future THE RATIONALE FOR INTRAPORTAL clinical application.
ISLET TRANSPLANTATION THE LIVER AS THE SITE
In normal nondiabetic conditions, insulin from the FOR ISLET TRANSPLANTATION:
pancreatic β-cells is secreted directly into the portal ve-HISTORICAL PERSPECTIVE nous system and is metabolized largely in the liver (64) . It was therefore reasoned that the liver may provide a The first described attempt to transplant pancreatic tissue for the treatment of diabetes was performed in physiologic environment for islets that enables the effective use of the secreted insulin (44) . The promising re-1893 (92), almost 30 years before the discovery of insulin. In the following 75 years, until a pancreas digestion sults of the first experimental and clinical transplants appeared to confirm this hypothesis (43) . It was recently method using collagenase was developed, many animal experiments related to Tx of whole pancreatic tissue reported that the insulin produced by islet allografts in type 1 diabetic patients was utilized in the liver in a rather than isolated islets. The sites of Tx included spleen, liver, peritoneal cavity, omentum, retroperitosimilar way to insulin produced by nondiabetic control subjects, with 80% being metabolized in the liver (55). neum, subcutaneous tissues, and gastric submucosa (4, 60) . It was also recognized that tissue Tx offers the Furthermore, intraportal infusion can today be performed by a minimal invasive procedure under local anpossibility for Tx into immunoprivileged sites, such as the anterior chamber of the eye and the testis (12, 22, 25) . esthesia after sedation, in an outpatient setting. Access to the portal vein is obtained by a percutaneous transheThese reports indicated that the search for the ideal site for islet Tx is not new. However, many early studies patic approach under ultrasound or fluoroscopic guidance (26,61). During the infusion, the portal venous reported poor outcomes in terms of reversal of diabetes or recipient survival because of the cotransplanted exopressure is monitored. Although not entirely free from complications, such as portal hypertension and bleeding, crine tissue that caused complications, such as autodigestion and fistula formation. To address this problem, this procedure can be considered safe and efficacious (61,89). Moreover, its minimal invasive characteristics rodent studies of Tx of fetal or neonatal pancreatic tissue were performed (25), because the exocrine component allow for repetitive infusions in the event that a first transplant does not result in normoglycemia. is still underdeveloped at these ages and the endocrine component still has the potential to grow. Early attempts UNFAVORABLE CONSEQUENCES OF with intramuscular Tx of human fetal pancreatic frag-INTRAPORTAL ISLET TRANSPLANTATION ments were relatively successful, with improvement in glucose control in three of 13 patients without immunoAlthough the results of clinical intraportal islet Tx have been superior over other sites, several characterissuppression (86).
With the development of the method of pancreas ditics of the liver and the portal venous system can hamper islet engraftment and survival. After intraportal Tx, the gestion using collagenase in 1967, rat islets could be isolated from the exocrine tissue (50) and, if transislets that were richly vascularized by arterial blood in the pancreas, now depend on oxygen diffusion from the planted into the peritoneal cavity of allogeneic diabetic rats, reduce blood glucose levels and polyuria (5) . In hypo-oxygenated portal venous blood [pO 2 10-15 mmHg vs. 40 mmHg in arterial blood (11)], until revascularizaovercome by the development of noninvasive imaging methods, such as magnetic resonance imaging (MRI) tion by the hepatic arterial system (36, 52) . It has been well demonstrated that hypoxia is an important apoptoand positron emission tomography (PET), to monitor the islet grafts (6,15). sis-inducing signal in β-cells (17) .
The portal system is the drainage system to the liver ISLET TRANSPLANTATION INTO for many toxins that are absorbed in the intestine, such THE RENAL SUBCAPSULAR SPACE as lipopolysaccharides (LPS) (68) . This is most likely
In murine models, the renal subcapsular space is the an important reason why the liver has an active innate most common site for Tx of islets to study immune reimmune system. In particular, liver macrophages (Kupfsponses, drug effects, and the result of genetic modificafer cells) play a key role in the early inflammatory tions ( Table 1 , Fig. 1 ). The diabetes reversal rates are events that occur after islet Tx (8) , and may induce a often high, even with limited numbers of islets. Tx into subsequent adaptive immune response (57). Tx into this a nonobese diabetic mouse without an effective immune immunoactive site is in contrast with the desire for imsystem, the so-called NOD-SCID mouse, has become mune hyporesponsiveness after Tx.
the gold standard for islet quality control after the islet Portal blood is hyperglycemic compared to systemic isolation process for most large-animal and clinical studblood, and chronic hyperglycemia can have toxic effects ies. However, in large animals and humans, investigaon the islets (69), although it should be noted here that tions of islet Tx beneath the kidney capsule are limited, toxic levels may not be reached in portal blood. In addimost likely due to the initial success of intraportal Tx. tion, the levels of orally administered immune suppressEarly attempts did not lead to any improvement in the ive agents are higher in the portal blood than after havdiabetic state, possibly because of a limited blood supply ing passed through the liver (first pass effect), and it is in the early post-Tx phase until revascularization takes debatable whether these high levels protect the grafted place (20, 35, 41) . Also, later clinical results, although islets or have harmful effects. Almost all currently used still before the introduction of the Edmonton protocol, immunosuppressive drugs have an adverse effect on β-were inferior to Tx into the liver (37) . cell function and survival (68, 94) .
Furthermore, the instant blood-mediated inflamma-ISLET TRANSPLANTATION tory reaction (IBMIR) is a major islet-disrupting event INTO THE SPLEEN that takes place when islets are infused into the bloodAnother option for intravenous Tx is retrograde infustream (7). The IBMIR is triggered by the exposure of sion into the splenic vein. In animal studies, Tx into the islet surface molecules, such as tissue factor, and the spleen offers the possibility of histological investigation production of inflammatory cytokines, possibly as a reafter splenectomy, while keeping the recipient alive sult of mechanical and chemical stress during the isola-(21). It was also hypothesized that a greater tissue voltion process (88). Upon direct contact with blood, this ume could be infused without the risk for portal hyperresults in activation of coagulation, platelets, and comtension (2), a known complication of intraportal infuplement, and the attraction of granulocytes, leading to sion. The spleen is well perfused with oxygenated blood islet disruption (7) . It is likely that it occurs not only and drains the released insulin into the portal circulation. after intraportal Tx, but after any intravascular infusion, In contrast, it can be expected that islet damage due to such as into the splenic vein.
inflammation (IBMIR) takes place after intrasplenic Tx, It has been investigated whether transplanted islets comparable with intraportal Tx. produce glucagon in response to hypoglycemia and thus Models of pancreatectomy and autoTx allow for studimprove hypoglycemia unawareness, a major indication ies of the site of Tx in the absence of immunologic barrifor islet Tx. It is thought that this response is impaired ers. In dogs, equal or even better results were achieved due to the lack of innervation of the grafted islets. This when the spleen was compared to the liver (2,41,47). In impairment was larger after intraportal Tx compared to clinical alloTx, one case was described of insulin indeintraperitoneal Tx in pancreatectomized dogs (29) . Bependence, although it concerned the Tx of pancreatic cause the liver is the site of endogenous glucose producmicrofragments from a juvenile donor (51) . A new evaltion, higher intrahepatic glucose levels could possibly uation of the spleen for islet Tx, however, will need to prevent the islets from sensing peripheral hypoglycemia prove advantageous over the liver, for which a much (62) .
broader experience has been established. Last, histological follow-up of graft survival or rejec-SUBCUTANEOUS ISLET TRANSPLANTATION tion is impossible after intraportal islet infusion as the islets will be randomly distributed throughout the portal From the viewpoint of patient safety, islet Tx under the skin is an attractive option. The site is easily accessivascular system. However, this problem may soon be ble for placement of the islet mass, allows for biopsies the systemic circulation. Although exogenous insulin therapy is able to control blood glucose values, islet Tx to monitor islet viability, and makes removal of the graft, if necessary, and re-Tx possible, all with the use with portal delivery of insulin is believed to be optimal for glucose metabolism. Moreover, subcutaneous islets of only minimally invasive procedures. A disadvantage is that the released insulin can reach the liver only via became necrotic after alloTx in humans (73) and in mice Figure 1 . Experience with various sites for islet transplantation in small-and large-animal models and in humans. Numbers in the figure correspond to numbers in Table 1 , in which the advantages and disadvantages of each site are elaborated.
(91), indicating suboptimal vascularization and insuffiVery recently, the results of alloTx in a nonhuman primate model were presented, and were encouraging; cient oxygenation and nutrient supply during the first few days after Tx. Compared to the subcutaneous tissue, islets were transplanted into the omentum, which was then sutured between the muscular layers of the abdomithe muscle may provide better conditions for revascularization; successful engraftment of autotransplanted isnal wall (45) . However, caution needs to be applied to this technique in a clinical setting, as the omentum can lets into a pediatric recipient has been reported (65) .
Alternatively, to address the problem of insufficient be a source of adhesions after surgical manipulation that can lead to intestinal strangulation, ileus, and internal oxygenation, studies in mice and rats have aimed at the prevascularization of the subcutaneous area by the imhernia (16) . Because of the likely occurrence of adhesions, we believe that islet Tx into the peritoneal cavity, plantation of biomaterials. Cylinders, bags, or mesh devices were placed under the skin 7 to 40 days prior to Tx as was attempted in early days (85), may not be a site of future interest. to induce the creation of a vascular bed (31,38,49,63) . In some cases, the biomaterials were designed to release ISLET TRANSPLANTATION INTO growth factors, such as fibroblast growth factor, to stim-THE GASTROINTESTINAL TRACT ulate angiogenesis (42, 56, 91) . After this period, the device was replaced with the islet graft or the islets were
The submucosal space of the gastrointestinal tract has several characteristics that could favor islet Tx into this placed inside the device. In all studies, the rate of reversal of diabetes was superior to that in control subjects site: a similar embryonic origin as the pancreas, rich vascular supply of oxygen and nutrients, and venous without prevascularization.
In addition, the placement of islets inside a device drainage into the portal blood stream. In culture, the intestinal submucosal matrix can provide a trophic envicould mechanically immunoisolate the islets, reducing or preventing cellular rejection, the dominant mecharonment for isolated islets (81) . A study of Tx in syngeneic hamsters demonstrated that islets can survive in this nism of islet rejection (77) . In a controversial report, xenoTx of neonatal pig islets in adolescent type 1 diaspace and reverse diabetes (80) . A preliminary report of a large-animal model demonstrated that autotransplanted betic patients was described, resulting in reduced insulin requirements in half of the 12 subjects and temporary islets can engraft in the gastric submucosal space of minipigs (9) . The islets were able to execute an insulin insulin independence in two, without the use of immunosuppression at any time (84) . It is not clear whether response following an arginine challenge 4 weeks after Tx (9). the reported beneficial effects were related to the chamber or to the cotransplanted Sertoli cells, which can have
The most physiological and therefore perhaps most supportive microenvironment for islets is the pancreas an immunomodulating effect (13, 79) .
With these new developments, subcutaneous islet Tx itself. Mouse islets retrieved 1 month after syngeneic Tx directly into the pancreas retained the ability to release may prove to be a promising technique. In particular, in the case of clinical xenotransplanation, it could offer a insulin in response to a glucose stimulus, while this response was absent in islets that had been transplanted controllable setting for this therapy; however, this work is still very much experimental.
into the liver (53) . In return, the hormone release by islets may ameliorate the exocrine function of the pan-ISLET TRANSPLANTATION creas that is often impaired in diabetic patients (78) .
INTO OMENTAL POUCHES
Prior to translation to a clinical application, it will be necessary to investigate the efficacy and safety of this Renewed interest in transplanting islets into a pouch created in the omentum has been shown in syngeneic rat procedure regarding cure of diabetes without induction of pancreatitis in larger animal models. studies (46). When applied in dogs after total pancreatectomy and autoTx, six out of six animals obtained IMMUNOLOGICALLY PRIVILEGED good islet function (30), whereas earlier experiments re-SITES AND TOLERANCE ported only 50% success (2,3). Islets engrafted in the omentum respond in a more physiological pattern than Tx of cells rather than whole organs introduces options for placement into sites where there is a reduced, when transplanted under the renal capsule, with respect to glucose metabolism and insulin sensitivity (28) . This absent, or suppressed immunological response, so-called immunoprivileged sites, such as the testis, brain, and aneffect is due to the direct drainage of insulin into the portal circulation. Other favorable circumstances in relaterior chamber of the eye. It was originally thought that immune privilege results from "immunologic ignorance" tion to the omentum are good vascularization and the ability to induce tissue repair, as has been applied in the (76) , but subsequent studies have shown that the mechanisms of immune privilege are much more complex and treatment of myocardial ischemia and in reconstructive plastic surgery through omental transposition (24) .
can involve Fas-Fas ligand interactions, an immune re- sponse deviated toward a Th2-like response (39, 40) , and to produce insulin in sufficient quantities to control glucose metabolism. During this period, both exogenous infailure of infiltrating T cells to acquire a direct cytotoxic function (48). In a carefully conducted rodent study, it sulin therapy and immunosuppression need to be administered to the recipient. was demonstrated that islet Tx into the testis induced CD4 +
CD25
+ T regulatory cells that were essential to The pig may offer a solution to the increasing need for transplantable islets. Pigs can provide an unlimited maintain a tolerant immune state (59) . Although these studies can provide great insight into the mechanisms of source of islets in quantities that may satisfy the metabolic requirements of diabetic patients, and that are able immune privilege, their clinical relevance may be rather low. This will hold as well for Tx into the anterior to produce insulin that functions in humans (82) . The reported 6-month survival of adult pig islets transplanted chamber of the eye (1) or into the brain (93).
Islet Tx into the thymus was attempted with the goal intraportally into nonhuman primates is promising (34), although clinical application will require significant to reeducating the immune system, leading to tolerance (90) . Islets survived in that site, but the recipients still modification to the immunosuppressive regimen. Finally, the pig offers opportunities for genetic modirequired immunosuppressive therapy and the mechanisms of tolerance were not studied extensively (90) .
fication that may help overcome some of the unfavorable site-specific conditions. For example, IBMIR may More information may soon become available from studies using vascularized thymic tissue in combination be reduced or prevented by islets from pigs transgenic for the human complement regulatory protein CD46 with islet and kidney Tx (87).
(membrane cofactor protein), or for human tissue factor CAN XENOTRANSPLANTATION OF ISLETS pathway inhibitor, human thrombomodulin, or human AT DIFFERENT DONOR AGES OVERCOME CD39, for "anticoagulation" (14) . Islets from neonatal SITE-SPECIFIC PROBLEMS?
piglets homozygous for gene-knockout of 1,3-galactosyltransferase are free of Galα1,3Gal (Gal) expression, The pig offers greater opportunities than humans to select a donor at an age when the islets have favorable whereas wild-type neonatal islets express Gal, which may be a target for xenoreactive natural antibodies (66). properties; islet-like cell clusters isolated from fetal or neonatal piglets retain the ability to mature and prolifer-CONCLUSIONS ate (54) , are believed to be less immunogenic than adult Although Tx into the liver is the current practice for islets, and are more resistant to hypoxia (18). As a result islet alloTx, it is now recognized that the liver may not of these characteristics, these types of islets may have a provide the conditions favoring optimal islet survival. In better survival potential at different recipient sites. In the particular, the major early loss of islet mass from IBMIR liver of nonhuman primates (NHP) survival and function requires the Tx of islets from more than one donor to of neonatal pig islets has been demonstrated (10) . In a achieve normoglycemia. In addition, the islets are expilot study more than a decade ago, fetal pig islets were posed to an active immune system, higher glucose and at least demonstrated to survive in humans and secrete immunosuppressive drug levels, and hypoxic conditions some insulin and C-peptide (27).
in the portal circulation. The Tx of porcine embryonic pancreatic tissue of Many alternative sites have been explored; some in exearly gestational age (29-56 days of 120 days total gesperimental settings aimed at clarifying immunological or tation) can avoid islet isolation procedures that can have biological processes, others aimed at providing an alternaharmful effects on the islets in the form of hypoxic, metive for clinical Tx. Eventually, the liver will most likely chanical, and chemical stress. In embryonic tissue, the be replaced by a site that can allow long-term survival of exocrine compartment remains undeveloped, and will islets from a single donor to reverse type 1 diabetes. develop only to a minimal extent after Tx into the rat
The pig can provide additional options as an islet doomentum (70). In contrast, the endocrine component has nor, perhaps by producing a genetically modified islet been shown to survive, expand, mature, and produce supply adjusted for the conditions at a particular transporcine insulin when transplanted under the kidney capplant site. sule of nude mice (19) or into the omentum of diabetic rats (70). The latter has the advantage that insulin is de- 
